Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
Analysts at BTIG Equity Research initiated coverage on Lombard Medical Inc (NASDAQ: EVAR) with a Buy rating and $9 price target Thursday.
Sean Lavin highlighted drivers for the firm:
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
The company's innovative Aorfix Stent graft has two significant opportunities. It is the only FDA label for highly-angulated aneurysm necks and analysts feel the stent may have advantages in tortuous iliacs.
The company is also in a compelling and expanding market. Analysts estimate the Endovascular aneurysm repair market is $1.5 billion and growing roughly six percent annually.
Moreover, Lavin feels that Lombard Medical is an attractive acquisition candidate given its enterprise value and potential market.
Shares of Lombard Medical recently traded at $7.77, up 7.9 percent.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.